Introduction {#Sec1}
============

The prevalence of GDM is on the rise in relation to an increase in predisposing maternal characteristics. The increase is more marked with application of IADPSG-WHO 2013 criteria \[[@CR1]\], with very high rates in special populations \[[@CR2]\].

Lifestyle modifications are the first step in the management of GDM and medical nutrition therapy is an essential component of it. Maternal diet should provide adequate energy intake to promote maternal and fetal health, help achieve glycemic goals and be culturally appropriate and individualized \[[@CR3]\]. DRI for normal weight pregnant women should be taken into account: provide no increase in energy requirement during the first trimester, + 340 kcal/day in the second trimester and + 452 kcal/day in the third; provide \> = 175 g carbohydrate/day, 71 g protein/day and 28 g fiber/day; and have an acceptable energy macronutrient distribution range (45--65% of energy from carbohydrates, 20--35% of energy from fat, 10--35% of energy from protein). However, little is known about the characteristics of diets consumed by women with GDM.

We aimed to characterize the dietary intake of women with GDM in usual clinical care.

Study protocol {#Sec2}
==============

We recently performed a systematic review and meta-analysis on RCTs addressing modified dietary interventions for the treatment of GDM and providing information on maternal glycemic control and birthweight-related variables \[[@CR4]\] (published protocol: PROSPERO CRD42016042391).

As a post hoc analysis, we have now examined the composition of diets used by the control group to characterize diets advised for treatment of GDM in usual clinical care. Data on ten dietary characteristics (kcal/day, % of energy provided by carbohydrates, protein, fat, monounsaturated fat, saturated fat and polyunsaturated fat, grams of fiber/day, glycemic index and load) were collected. Glycemic index is defined as the incremental area under the blood glucose curve following the ingestion of a test food, expressed as percentage of the corresponding area following an equivalent load of a reference carbohydrate. The glycemic load takes into account the amount of food intake.

We have used STATA 14.0 and a random effects model to pool the diet characteristics. Heterogeneity was assessed using *I*^2^ statistics and Cochran's *Q* test. A figure displaying worldwide carbohydrate energy contribution was constructed using the carbohydrate intake of studies providing this information (filled circle) and carbohydrate advice (open circle) when intake was not available.

Results {#Sec3}
=======

Out of 3660 records identified through database search and 128 from other sources, 126 full-text articles were assessed for eligibility and 18 studies were included in the meta-analysis of glycemic control and birthweight-related variables \[[@CR4]\]. Thirteen of these studies provided quantitative information on one or more diet characteristics and were included in the current meta-analysis and graphical display. The carbohydrate intake was the diet characteristic most frequently reported (*N* = 12). Other studies only reported diet recommendations and the four of them giving data on carbohydrate advice were included for graphical display.

In the 13 studies included in the current analysis, the modified dietary intervention used for treatment of GDM was as follows: a low glycemic index diet (*N* = 4), a low carbohydrate diet (*N* = 1), Dietary Approaches to Stop Hypertension (*N* = 3), modification of dietary fat (*N* = 2), soy protein enrichment (*N* = 1), behavioral intervention (*N* = 1), and calorie restriction (*N* = 1). The information in the intervention arm is not used in the current analysis.

Pooled estimates on control diet characteristics are summarized in Table [1](#Tab1){ref-type="table"}. High heterogeneity was observed in the ten diet characteristics (*I*^2^ ranging from 94.8 for glycemic load to 99.2 for % of energy from polyunsaturated fat; *p* for heterogeneity \< 0.001 for all of them).

Table 1Characteristics of control diet in RCTs addressing modified dietary interventions for GDM treatment (pooled estimates)Characteristic*N* studiesMedianCI 95%*I* ^2^*P* heterogeneityEnergy (Kcal/day)102094.01931.9--225698.1\< 0.001% of energy from carbohydrates1249.145.1--53.198.5\< 0.001% of energy from proteins1119.017.1--20.998.5\< 0.001% of energy from total fat1131.528.6--34.497.7\< 0.001% of energy from saturated fat79.68.3--10.896.6\< 0.001% of energy from polyunsaturated fat69.58.3--10.799.2\< 0.001% of energy from monounsaturated fat310.16.1--14.196.8\< 0.001Glycemic index454.351.2--57.598.1\< 0.001Glycemic load3122.3108.1--136.494.8\< 0.001Fiber (g/day)1021.618.9--24.298.0\< 0.001

The dietary carbohydrate content of control diets in individual trials is displayed in Fig. [1](#Fig1){ref-type="fig"}. Carbohydrate contribution to energy intake ranged from moderate restriction (36.2% in Australia) to the upper range of the acceptable macronutrient distribution range (60.0%, Poland).

Fig. 1Energy derived from carbohydrates in control diets of RCTs addressing modified dietary interventions for treatment of GDM by trial site

Discussion {#Sec4}
==========

In this subanalysis addressing control diets in RCTs on modified dietary interventions for GDM, we observed a high heterogeneity in the ten analyzed characteristics. This information has not been previously reported.

The figures of carbohydrate content of control diets parallel with some exceptions the diet composition in the background population according to FAO statistics \[[@CR5]\] with the incorporation of some degree of carbohydrate restriction.

It is of note that specific dietary recommendations with regard to energy-yielding nutrients are lacking for treatment of GDM. A limitation of the current analysis is that we did not perform a specific systematic review and meta-analysis to address this topic but a subanalysis of a previous one \[[@CR4]\]. However, current results can serve as an estimation of diets usually advised to women with GDM. Another limitation is that the number of meals and snacks was not addressed.

We conclude that control diets used in RCTs addressing modified dietary intervention in women with GDM display marked heterogeneity in all analyzed characteristics, probably reflecting the diet properties of the background population. This is desirable from the cultural and socioeconomic point of view, but may have an impact on the response to nutritional management of GDM and should be addressed in future research.
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